BPTS
Income statement / Annual
Last year (2023), Biophytis S.A.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Biophytis S.A.'s net income was -$17.03 M.
See Biophytis S.A.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$803,000.00
|
$484,000.00
|
$311,000.00
|
$280,000.00
|
$262,000.00
|
$227,000.00
|
$204,000.00
|
$167,000.00
|
$65,000.00
|
$0.00
|
| Gross Profit |
-$803,000.00
|
-$484,000.00
|
-$311,000.00
|
-$280,000.00
|
-$262,000.00
|
-$227,000.00
|
-$204,000.00
|
-$167,000.00
|
-$65,000.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.41 M
|
$16.03 M
|
$19.67 M
|
$9.92 M
|
$9.09 M
|
$9.51 M
|
$7.04 M
|
$5.12 M
|
$1.57 M
|
$725,635.00
|
| General & Administrative Expenses |
$5.49 M
|
$7.24 M
|
$7.15 M
|
$4.02 M
|
$6.59 M
|
$4.35 M
|
$2.87 M
|
$2.82 M
|
$2.07 M
|
$373,468.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$124,466.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.49 M
|
$7.24 M
|
$7.15 M
|
$4.02 M
|
$6.59 M
|
$4.35 M
|
$2.87 M
|
$2.82 M
|
$2.07 M
|
$373,468.00
|
| Other Expenses |
-$1.56 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$1.00
|
-$1.00
|
| Operating Expenses |
$14.33 M
|
$23.27 M
|
$26.82 M
|
$13.94 M
|
$15.68 M
|
$13.86 M
|
$9.91 M
|
$7.94 M
|
$3.10 M
|
$673,979.00
|
| Cost And Expenses |
$14.33 M
|
$23.27 M
|
$26.82 M
|
$13.94 M
|
$15.68 M
|
$13.86 M
|
$9.91 M
|
$7.94 M
|
$3.10 M
|
$673,979.00
|
| Interest Income |
$0.00
|
$990,000.00
|
$20,000.00
|
$34,000.00
|
$1,445.00
|
$0.00
|
$37,000.00
|
$22,000.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.25 M
|
$1.60 M
|
$4.43 M
|
$4.37 M
|
$2.53 M
|
$185,000.00
|
$3.29 M
|
$35,000.00
|
$172,500.00
|
$0.00
|
| Depreciation & Amortization |
$529,000.00
|
$484,000.00
|
$311,000.00
|
$280,000.00
|
$262,000.00
|
$227,000.00
|
$204,000.00
|
$167,000.00
|
-$65,003.00
|
$15,427.00
|
| EBITDA |
-$13.80 M |
-$23.04 M |
-$26.50 M |
-$13.66 M |
-$15.42 M |
-$13.63 M |
-$9.81 M |
-$7.78 M |
-$4.98 M |
-$704,635.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$4.25 M
|
-$944,000.00
|
-$4.35 M
|
-$11.58 M
|
-$2.13 M
|
-$198,000.00
|
-$1.50 M
|
-$12,000.00
|
-$190,000.00
|
-$35,789.00
|
| Income Before Tax |
-$18.59 M
|
-$24.22 M
|
-$31.25 M
|
-$17.05 M
|
-$17.82 M
|
-$14.06 M
|
-$11.41 M
|
-$7.95 M
|
-$3.29 M
|
-$709,768.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.56 M
|
-$1.52 M
|
$2.28 M
|
$4.37 M
|
-$28,000.00
|
-$72,000.00
|
$1.50 M
|
$13,000.00
|
$65,003.00
|
$34,960.00
|
| Net Income |
-$17.03 M
|
-$24.22 M
|
-$31.16 M
|
-$25.52 M
|
-$18.95 M
|
-$13.99 M
|
-$11.41 M
|
-$7.95 M
|
-$5.23 M
|
-$708,939.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-12.55 |
-56.06 |
-105.64 |
-172.41 |
-451.1 |
-423.85 |
-518.55 |
-530.27 |
-436 |
-50.64 |
| EPS Diluted |
-12.54 |
-55.4 |
-105.38 |
-170.19 |
-448.88 |
-418.32 |
-496.65 |
-512.93 |
-430.09 |
-47.56 |
| Weighted Average Shares Out |
$1.36 M
|
$432,000.00
|
$295,000.00
|
$148,000.00
|
$42,000.00
|
$33,000.00
|
$22,000.00
|
$15,000.00
|
$12,000.00
|
$14,000.00
|
| Weighted Average Shares Out Diluted |
$1.36 M
|
$437,098.00
|
$295,707.00
|
$149,936.00
|
$42,207.00
|
$33,436.00
|
$22,970.00
|
$15,507.00
|
$12,165.00
|
$14,906.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
